ASX Share rice
Mon 17 May 2021 - 11:19:am (Sydney)

PME Share Price

PRO MEDICUS LIMITEDPMEHealth Care Equipment & Services

PME Company Information

Name:

Pro Medicus Limited

Sector:

Healthcare

Industry:

Health Information Services

GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology

Address:

450 Swan Street Richmond VIC Australia 3121

Phone:

61 3 9429 8800

Co-Founder, CEO, MD & Exec. Director:

Dr. Sam Aaron Hupert M.D., M.B.B.S.

Co-Founder, Technology Director & Exec. Director:

Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc.

GM of Europe & Global CTO:

Dr. Malte Westerhoff

GM of North America & Global Head of Marketing:

Mr. Brad Levin

Global Head of Sales - Visage Imaging Inc:

Mr. Sean Lambright

CFO & Company Sec.:

Mr. Clayton James Hatch CPA, B.Comm, CPA

Company Overview:

Pro Medicus Limited provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions in Australia, Europe, and North America. It offers medical software for practice management; integration products; Promedicus.net secure email; healthcare software that provides radiologist and clinicians with advanced visualization capability for viewing 2-D, 3-D, and 4-D medical images; and PACS/Digital imaging software. The company offers its products under the Visage RIS, Visage RIS/PACS, and Visage 7 names. It also provides Visage Ease Pro, a mobile applications, which allow users access to medical imaging results that are stored on a Visage 7 server; training, installation, and professional services; and after sale support and service products. The company offers its products and services to hospitals, diagnostic imaging groups, and other health related entities. Pro Medicus Limited was founded in 1983 and is headquartered in Richmond, Australia.

PME Share Price Information

Shares Issued:

104.21M

Market Capitalisation:

$4.42B

Dividend per Share:

$0.13

Ex Dividend Date:

2021-03-04

Dividend Yield:

0.31%

Revenue (TTM):

$59.12M

Revenue Per Share (TTM):

$0.57

Earnings per Share:

$0.235

Profit Margin:

0.4155

Operating Margin (TTM):

$0.57

Return On Assets (TTM):

$0.22

Return On Equity (TTM):

$0.40

Quarterly Revenue Growth (YOY):

0.078

Gross Profit(TTM):

$56.47M

Diluted Earnings Per Share (TTM):

$0.235

QuarterlyEarnings Growth(YOY):

0.122

PME CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-7,699,000

Change To Liabilities:

$-1,324,000

Total Cashflow From Investing Activities:

$-7,699,000

Net Borrowings:

$-557,000

Net Income:

$23.08M

Total Cash From Operating Activities:

$31.42M

Depreciation:

$845K

Other Cashflow From Investing Activities:

$172K

Dividends Paid:

$-10,916,000

Change To Inventory:

$-4,000

Change To Account Receivables:

$4.80M

Sale Purchase Of Stock:

$-842,000

Capital Expenditures:

$363K

PME Income Statement

Income Date:

2020-06-30

Income Before Tax:

$30.02M

Net Income:

$23.08M

Gross Profit:

$56.64M

Operating Income:

$30.02M

Other Operating Expenses:

$857K

Interest Expense:

$218K

Income Tax Expense:

$6.94M

Total Revenue:

$56.99M

Cost Of Revenue:

$355K

PME Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$18.84M

Total Liabilities:

$35.46M

Total Stockholder Equity:

$60.18M

Other Current Liabilities:

$9.03M

Total Assets:

$95.65M

Common Stock:

$1.96M

Other Current Assets:

$45K

Retained Earnings:

$49.62M

Other Liabilities:

$20.99M

Other Assets:

$12.48M

Cash:

$43.41M

Total Current Liabilities:

$12.72M

Property - Plant & Equipment:

$2.85M

Net Tangible Assets:

$41.34M

Total Current Assets:

$61.48M

Net Receivables:

$17.01M

Short-Term Investments:

$34.16M

Inventory:

$35K

Accounts Payable:

$835K

Non Currrent Assets (Other):

$0.99M

Short-Term Investments:

$34.16

Non Current Liabilities Total:

$22.75M

PME Share Price History

PME News

27 Apr, 2021
A look at the shareholders of Pro Medicus Limited ( ASX:PME ) can tell us which group is most powerful. Large companies...
18 Mar, 2021
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
31 Jan, 2021
Most readers would already be aware that Pro Medicus' (ASX:PME) stock increased significantly by 34% over the past...
01 Jan, 2021
Sam Hupert has been the CEO of Pro Medicus Limited ( ASX:PME ) since 2010, and this article will examine the...
06 Dec, 2020
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
10 Nov, 2020
Every investor in Pro Medicus Limited (ASX:PME) should be aware of the most powerful shareholder groups. Insiders...
12 Oct, 2020
We think all investors should try to buy and hold high quality multi-year winners. While the best companies are hard...
16 Sep, 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
12 Jul, 2020
It is hard to get excited after looking at Pro Medicus' (ASX:PME) recent performance, when its stock has declined 8.9...
26 Jun, 2020
13:00
Yahoo! Finance
Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the latest version of the VisageĀ® 7 Enterprise Imaging Platform, Visage 7.1.15, has been released for global availability. Visage is scheduling online demonstrations of Visage 7 coinciding with the virtual Society for Imaging Informatics in Medicine 2020 (SIIM20) annual meeting, June 24-26.

PME Dividend Payments

EX-Date Dividend Amount
2010-09-10$0.0200
2012-03-01$0.0050
2012-09-10$0.0100
2013-03-04$0.0100
2013-09-09$0.0100
2014-03-03$0.0100
2014-09-10$0.0100
2015-03-04$0.0100
2015-09-09$0.0100
2016-03-10$0.0150
2016-09-08$0.0150
2017-03-09$0.0150
2017-09-07$0.0250
2018-03-08$0.0250
2018-09-06$0.0350
2019-03-07$0.0350
2019-09-12$0.0450
2020-03-05$0.0600
2020-09-10$0.0600
2021-03-04$0.0700

PME Dividends (last 11 Years)